NANOCHIP® GIPGASTROINTESTINALPANELCOMBIII - COFEPRIS Registration 155R2020 SSA
Access comprehensive regulatory information for NANOCHIP® GIPGASTROINTESTINALPANELCOMBIII (NANOCHIP® GIPGASTROINTESTINALPANELCOMBIII) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 155R2020 SSA and manufactured by PHARMACUR, S.A. DE C.V.. The device was registered on February 13, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
ES UNA PRUEBA DE DIAGNÓSTICO IN VITROAUTOMATIZADA PARA LA DETECCIÓN YDIFERENCIACIÓNDIRECTADELASBACTERIASYPARÁSITOS DE DIARREA HUMANA EN MUESTRAS DE HECES DE PACIENTES SINTOMÁTICOS.
IT IS AN AUTOMATED IN VITRO DIAGNOSTIC TEST FOR THE DIRECT DETECTION AND DIFFERENTIATION OF HUMAN DIARRHEA BACTERIA AND PARASITES IN STOOL SAMPLES FROM SYMPTOMATIC PATIENTS.